Lv4
650 积分 2024-09-16 加入
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2天前
已完结
Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients
2天前
已完结
Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors
7天前
已完结
Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients
22天前
已完结
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
27天前
已完结
Chemotherapy time interval and development of platinum and taxane resistance in ovarian, fallopian, and peritoneal carcinomas
1个月前
已完结
Patient-derived ovarian cancer organoids as platforms for predicting platinum resistance and screening tumor stem cell inhibitors
1个月前
已完结
Targeting ADAR1 lactylation activates innate immune and overcomes chemoresistance in ovarian cancer
1个月前
已完结
Immune escape between endoplasmic reticulum stress-related cancer cells and exhausted CD8+T cells leads to neoadjuvant chemotherapy resistance in ovarian cancer
2个月前
已完结
PD-L1 expression and CD8+ Tumor-infiltrating lymphocytes in different types of tuboovarian carcinoma and their prognostic value in high-grade serous carcinoma
2个月前
已完结
皖公网安备34019202002308
